$XAIR
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Healthcare
Sector
Medical - Devices
Industry
Steven Adam Lisi
CEO
107
Employees
$2.23
Current Price
$4.48M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 1 | 2 | $48,861.87 | 18,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 1 | 4 | $62,351.87 | 23,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 1 | 4 | $62,351.87 | 23,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | Lin Yi-Chien 10% Owner | Purchase | 2,607 | $2.21 | $5,761.47 | View Details |
| Sep 29, 2026 | Lin Yi-Chien 10% Owner | Purchase | 3,000 | $2.69 | $8,070.00 | View Details |
| Sep 30, 2026 | Lin Yi-Chien 10% Owner | Purchase | 2,000 | $2.71 | $5,420.00 | View Details |
| Oct 1, 2026 | Lin Yi-Chien 10% Owner | Purchase | 15,393 | $2.80 | $43,100.40 | View Details |
1 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$3.31
ActualN/A
Revenue
Estimated$2.16M
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.